GenVec (GNVC) Reports In-line Results for Q3
More News related to GNVC
- GenVec (GNVC) Reports In-line Results for Q3
- GenVec Reports Third Quarter 2009 Financial Results
- SAIC-Frederick Signs $22M Contract with GenVec (GNVC) for Flu and HIV Vaccine Development
- GenVec Signs New Contract to Support HIV and Influenza Vaccine Development
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
More News related to Earnings
- Quicksilver Resources (KWK) Granted Motion for Partial Summary by Texas in BreitBurn (BBEP) Lawsuit
- American International Group (AIG) Implementing Benmosche's Compensation Agreement
- Sun American (SAMB) Receives Listing Rule 5450 Notification from NASDAQ
- Solutia (SOA) To Discontinue Manufacturing at its Plant in Cologne, Germany
- General Dynamics (GD) Business Unit Awarded $2.2B U.S. Army SAC Contract for 724 LAV's
GenVec, Inc. (NASDAQ: GNVC) reports a Q3 loss of $0.04, in-line with the analyst estimate of ($0.04). Revenue for the quarter was $2.9 million, which compares to the estimate of $5 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
